Baseline heterogeneous NF-κB signaling levels within individual cells of a tumor and between individual tumors were confirmed using two different bioluminescence-based NF-κB transcriptional activation reporters at single cell resolution, as well as in two different tumor models (melanoma and pancreas). The gene discussed is NFKB1; the disease is neoplasm.